Penn State faculty participate in several national clinical research studies, including the Age-Related Eye Disease Study II, Pediatric Eye Disease Interest Group, Diabetic Retinopathy clinical Research Network, and Standard Care vs. Corticosteroid for Retinal Vein Occlusion Study. These National Eye Institute-supported projects provide our patients access to the most advanced treatment options. Our clinical studies are conducted through the Lions clinical Research Unit, which provides high-quality, personalized and confidential care for patients who participate in clinical studies.
Penn State researchers have identified key pathways to stimulate healing of the cornea after injuries. Through their National Eye Institute grant, they discovered that drugs controlling the opioid growth factor system can accelerate wound healing in the cornea. This approach may be particularly helpful for people with diabetes or recurrent corneal erosions.
The PSH Retina Research Labs continue basic research in vision loss due to diabetic retinopathy. With funding from the National Eye Institute, the Juvenile Diabetes Research Foundation, American Diabetes Association and the PA Lions Club International, they are developing and testing new treatments to counteract vision loss in diabetes.